2003;42:1206 52. S8.1.6.1-2. Law MR, Wald NJ, Morris JK, et al. Value of low dose combina- tion treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003;326:1427. S8.1.6.1-3. Bangalore S, Kamalakkannan G, Parkar S, et al. Fixed-dose com- binations improve medication compliance: a meta-analysis. Am J Med. 2007;120:713 9. S8.1.6.1-4. Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417 28. S8.1.6.1-5. Sundstrom J, Arima H, Jackson R, et al. Effects of blood pressure reduction in mild hypertension: a systematic review and meta- analysis. Ann Intern Med. 2015;162:184 91. S8.1.6.1-6. Luders S, Schrader J, Berger J, et al. The PHARAO study: pre- vention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League. J Hypertens. 2008;26:1487 96. S8.1.6.1-7. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study. JAMA. 1977;237:255 61. 8.2. Achieving BP Control in Individual Patients S8.2-1. Neaton JD, Grimm RH Jr, Prineas RJ, et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA. 1993;270:713 24. S8.2-2. Senn S. Individual response to treatment: is it a valid assumption? BMJ. 2004;329:966 8. 8.3. Follow-Up of BP During Antihypertensive Drug Therapy S8.3-1. Ambrosius WT, Sink KM, Foy CG, et al. The design and ratio- nale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials. 2014;11:532 46. S8.3-2. Cushman WC, Grimm RH Jr, Cutler JA, et al. Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007;99:44i 55i. 